Concepedia

Ling-Zhi Xu

LX

Statistics

Publications

4

Citations

260

H-Index

4

Active since

2014

Affiliations

Sun Yat-sen University(Current)

Sun Yat-sen University Cancer Center

Dalian Medical University

First Affiliated Hospital of Dalian Medical University

State Key Laboratory of Oncology in South China

Ling-Zhi Xu is an author at Sun Yat-sen University specializing in oncology, medicine, and cancer stem cells.

Publications per year

2014–2017

4

Publications

4

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells

Zhi-Jie Hou, Xi Luo, Wei Zhang et al. · Oncotarget · 2015 · 88 citations · Full text

, , +12

p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis

Si-Si Li, Ling-Zhi Xu, Wei Zhou et al. · Carcinogenesis · 2017 · 72 citations · Full text

, , +7

A Novel Small-Molecule Aurora Kinase Inhibitor Attenuates Breast Tumor–Initiating Cells and Overcomes Drug Resistance

Fei-Meng Zheng, Zi-Jie Long, Zhi-Jie Hou et al. · Molecular Cancer Therapeutics · 2014 · 66 citations

, , +16

Aurora kinase A suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells

Ling-Zhi Xu, Zi-Jie Long, Fei Peng et al. · Oncotarget · 2014 · 34 citations · Full text

, , +17

1–4 of 4